Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
Recruiting · NCT06642844 · Registry updated 2026-06-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment | Unresectable Metastatic Colorectal Cancer | Recruiting | Phase 3 | 2026-06-16 | NCT06642844 |
24 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BORG | Besançon | France | 1 |
| Caroline Petorin | Clermont-Ferrand | France | 1 |
| David Tougeron | Poitiers | France | 1 |
| Ducreux | Gustave Roussy | France | 1 |